Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants

Details for Australian Patent Application No. 2003225256 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Light, David; Mclean, Kirk

Agent Davies Collison Cave

Pub. Number AU-B-2003225256

PCT Number PCT/US03/13522

PCT Pub. Number WO2003/092602

Priority 60/376,566 01.05.02 US

Filing date 30 April 2003

Wipo publication date 17 November 2003

Acceptance publication date 4 June 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61L 33/00 (2006.01) Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/485 (2006.01) Peptides having more than 20 amino acids

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/36 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/376,566 01.05.02 US

8 January 2004 Application Open to Public Inspection

  Published as AU-B-2003225256

7 May 2009 Alteration of Name

  The name of the applicant has been altered to Bayer Schering Pharma Aktiengesellschaft 2003245776 2158141 Ontario Inc. The name of the applicant has been altered to Cellometrics Inc. 2004

4 June 2009 Application Accepted

  Published as AU-B-2003225256

1 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003225257-LIGATION CLIP APPLIER AND METHOD

2003225255-Novel tissue factor targeted antibodies as anticoagulants